Comorbidities in obstructive lung disease in Korea: Data from the fourth and fifth Korean national health and nutrition examination survey

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 1571-1582

  Park, Hee Jin ^a   Leem, Ah Young ^a   Lee, Sang Hoon ^a   Song, Ju Han ^a   Park, Moo Suk ^a   Kim, Young Sam ^a   Kim, Se Kyu ^a   Chang, Joon ^a   Chung, Kyung Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Chronic obstructive pulmonary disease; Comorbidity; Hypertension; Underweight

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; OSTEOARTHRITIS; PREVALENCE; SOUTH KOREA; SPIROMETRY; UNDERWEIGHT; AGED; BODY WEIGHT; CROSS-SECTIONAL STUDY; DYSLIPIDEMIAS; INCIDENCE; LUNG; MIDDLE AGED; NUTRITION; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; TIME FACTOR; VITAL CAPACITY;

ADULT; AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERTENSION; INCIDENCE; LUNG; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SPIROMETRY; SURVEYS AND QUESTIONNAIRES; THINNESS; TIME FACTORS; VITAL CAPACITY;

EID: 84939241535     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S85767     Document Type: Article

References (50)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Lung Disease; 2014.
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765-773.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
4. Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (gold) -why and what? Clin Respir J. 2012;6:208-214.
5. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319-338.
6. Consultation WHOE. Appropriate body-mass index for asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
7. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31:204-212.
8. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128:2099-2107.
9. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J. 2008;31:492-501.
10. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:728-735.
11. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32:962-969.
12. Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006; 16:63-70.
13. Miller J, Edwards LD, Agusti A, et al; Evaluation of CLtIPSEI. Comorbidity, systemic inflammation and outcomes in the eclipse cohort. Respir Med. 2013;107:1376-1384.
14. Tan WC, Ng TP. COPD in Asia: where east meets west. Chest. 2008; 133:517-527.
15. Joo H, Park J, Lee SD, Oh YM. Comorbidities of chronic obstructive pulmonary disease in koreans: a population-based study. J Korean Med Sci. 2012;27:901-906.
16. Steuten LM, Creutzberg EC, Vrijhoef HJ, Wouters EF. COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J. 2006;15:84-91.
17. Kim SB, Kang YA, Jung JY, et al. Body mass index and fat free mass index in obstructive lung disease in Korea. Int J Tuberc Lung Dis. 2014;18: 102-108.
18. Baarends EM, Schols AM, Pannemans DL, Westerterp KR, Wouters EF. Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;155: 549-554.
19. Debigare R, Marquis K, Cote CH, et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest. 2003;124:83-89.
20. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1414-1418.
21. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-1012.
22. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1856-1861.
23. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:155-161.
24. Mapel DW, Dedrick D, Davis K. Trends and cardiovascular co-morbidities of COPD patients in the veterans administration medical system, 1991-1999. COPD. 2005;2:35-41.
25. Agusti A, Calverley PM, Celli B, et al; Evaluation of CLtIPSEi. Charac­terisation of COPD heterogeneity in the eclipse cohort. Respir Res. 2010;11:122.
26. Baty F, Putora PM, Isenring B, Blum T, Brutsche M. Comorbidities and burden of COPD: A population based case-control study. PLoS One. 2013;8:e63285.
27. Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871-888.
28. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest. 2005;128:2005-2011.
29. Barr RG, Celli BR, Mannino DM, et al. Comorbidities, patient knowl­edge, and disease management in a national sample of patients with COPD. Am J Med. 2009;122:348-355.
30. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370:797-799.
31. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5:549-555.
32. Spies CM, Strehl C, van der Goes MC, Bijlsma JW, Buttgereit F. Glucocorticoids. Best Pract Res Clin Rheumatol. 2011;25:891-900.
33. Lavi S, Prasad A, Yang EH, et al. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation. 2007;115:2621-2627.
34. Basili S, Ferroni P, Vieri M, et al. Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease. Atherosclerosis. 1999;147:249-252.
35. Humayun A, Shah AS, Alam S, Hussein H. Relationship of body mass index and dyslipidemia in different age groups of male and female popu­lation of Peshawar. J Ayub Med Coll Abbottabad. 2009;21:141-144.
36. Malnick SD, Knobler H. The medical complications of obesity. QJM. 2006;99:565-579.
37. Izquierdo JL, Martinez A, Guzman E, de Lucas P, Rodriguez JM. Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors. Int J Chron Obstruct Pulmon Dis. 2010;5:387-394.
38. Silverberg DS, Mor R, Weu MT, Schwartz D, Schwartz IF, Chernin G. Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm Med. 2014;14:24.
39. Similowski T, Agusti A, MacNee W, Schonhofer B. The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006;27:390-396.
40. John M, Lange A, Hoernig S, Witt C, Anker SD. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol. 2006;111:365-370.
41. Boutou AK, Hopkinson NS, Polkey MI. Anaemia in chronic obstructive pulmonary disease: an insight into its prevalence and pathophysiology. Clin Sci. 2015;128:283-295.
42. Bolton CE, Cannings-John R, Edwards PH, et al. What community measurements can be used to predict bone disease in patients with COPD? Respir Med. 2008;102:651-657.
43. Bolton CE, Ionescu AA, Shiels KM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary dis­ease. Am J Respir Crit Care Med. 2004;170:1286-1293.
44. Kjensli A, Mowinckel P, Ryg MS, Falch JA. Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone. 2007;40:493-497.
45. Vrieze A, de Greef MH, Wijkstra PJ, Wempe JB. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int. 2007;18:1197-1202.
46. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59:574-580.
47. Graat-Verboom L, Wouters EF, Smeenk FW, van den Borne BE, Lunde R, Spruit MA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J. 2009;34:209-218.
48. Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. Arch Intern Med. 2000;160:2653-2658.
49. Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 2012;12:26.
50. Echave-Sustaeta JM, Casanova LC, Cosio BG, Soler-Cataluña JJ, Garcia-Lujan R. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity? Int J Chron Obstruct Pulmon Dis. 2014;9:1307-1314.